T78.40XA

Allergy, unspecified, initial encounter

T78.40XA is a diagnostic code utilized within the ICD-10-CM framework to classify an allergic reaction of unspecified nature during the initial encounter. Allergic reactions occur when the immune system overreacts to a foreign substance—such as pollen, venom, or food—that typically does not cause a reaction in most people. This specific code is applied when the specific allergen has not yet been identified or documented, and the patient is currently receiving active treatment for the acute phase of the hypersensitivity event. The clinical presentation of an unspecified allergy can range from localized cutaneous manifestations to systemic involvement. Since this is an initial encounter, the focus is on clinical stabilization, diagnostic evaluation to identify potential triggers, and acute management of the immune response.

Clinical Symptoms

  • Pruritus (intense itching)
  • Urticaria (hives or wheals)
  • Angioedema (swelling of the face, lips, or tongue)
  • Erythema (skin redness)
  • Allergic rhinitis (sneezing, congestion)
  • Conjunctivitis (itchy, watery eyes)
  • Dyspnea (shortness of breath)
  • Wheezing
  • Tachycardia (rapid heart rate)
  • Hypotension
  • Abdominal cramping
  • Nausea and vomiting
  • Diarrhea
  • Coughing
  • Laryngeal edema

Common Causes

  • Exposure to unidentified environmental aeroallergens
  • Ingestion of unknown food allergens
  • Hypersensitivity to pharmaceutical agents (e.g., antibiotics, NSAIDs)
  • Hymenoptera venom exposure (insect stings)
  • Contact with latex or industrial chemicals
  • Genetic predisposition to atopic conditions
  • Cross-reactivity between different allergens
  • Previous sensitization to a specific but unknown trigger

Documentation & Coding Tips

Differentiate between unspecified allergy and other specific allergic reactions to avoid audit triggers.

Example: Patient presents for an initial encounter regarding a generalized skin rash and pruritus of unknown origin. The physical exam confirms diffuse urticaria on the trunk and limbs following exposure to an unknown environmental trigger. Diagnosis: Allergy, unspecified, initial encounter (T78.40XA). Billing Focus: The documentation specifies this as the initial encounter (A) for active treatment of an acute allergic episode. Risk Adjustment: Accurate capture of the unspecified status supports the initial diagnostic phase before more specific HCC-weighted conditions like anaphylaxis are identified.

Billing Focus: The 7th character A must be used for the period when the patient is receiving active treatment for the condition.

Document the absence of systemic involvement or anaphylaxis to justify the use of T78.40XA over more severe codes.

Example: Subjective: Patient reports sudden onset of itching after a meal. Objective: Stable vitals, no wheezing, no angioedema, no hypotension. Assessment: Allergy, unspecified (T78.40XA), initial encounter. Plan: Administer antihistamine and monitor for 30 minutes. Billing Focus: Clearly documenting the lack of systemic symptoms supports the use of a non-anaphylactic code and justifies a lower-level E/M code such as 99213. Risk Adjustment: Documentation of the absence of complications ensures the record accurately reflects the patient's severity of illness (SOI).

Billing Focus: Detailed symptom documentation (e.g., absence of respiratory distress) supports code selection and prevents upcoding.

Always specify the episode of care using the appropriate 7th character for injury and poisoning codes.

Example: Patient returns for initial evaluation of an acute allergic reaction that started two hours ago. This is the first time the patient is being seen for this specific episode. Assessment: T78.40XA. Billing Focus: Laterality is not applicable here, but the 7th character A identifies this as the initial encounter. Risk Adjustment: Essential for tracking the progression of an acute event across the continuum of care.

Billing Focus: Correct use of the 7th character A for initial encounters versus D for subsequent or S for sequela.

Link the allergy code with a manifestation code if the clinical presentation is specific.

Example: Evaluation of a 28-year-old male with acute allergic urticaria (L50.0) following contact with an unknown substance. Diagnosis: Allergy, unspecified (T78.40XA) and Allergic urticaria (L50.0). Billing Focus: Use T78.40XA as the primary code for the underlying allergic state and L50.0 for the manifestation. Risk Adjustment: Providing both codes increases the clinical specificity and detail of the patient's health status.

Billing Focus: Manifestation codes (like L50.0) should be reported alongside the T-code when applicable.

Explicitly state the medical necessity for allergy testing when using an unspecified code.

Example: Initial encounter for unspecified allergy. Due to the unknown nature of the trigger and the severity of the rash, percutaneous skin testing (95004) is scheduled to prevent future anaphylaxis. Billing Focus: Documenting the need to identify the allergen justifies the use of 95004 during the follow-up. Risk Adjustment: Identifying specific triggers eventually leads to more precise coding (e.g., peanut allergy), which has higher risk implications.

Billing Focus: Provides the documentation bridge between an unspecified diagnosis and specific diagnostic procedures.

Relevant CPT Codes

Related Diagnoses

Hierarchy